Erythrocyte antioxidant activity in human patients with Parkinson's disease
- PMID: 3587738
- DOI: 10.1016/0304-3940(87)90547-7
Erythrocyte antioxidant activity in human patients with Parkinson's disease
Abstract
Three groups have reported defective antioxidant mechanisms in substantia nigra of patients with Parkinson's disease, namely a decreased catalase and peroxidase activity, a reduction of glutathione and, more recently, a diminished nigral glutathione peroxidase activity. We decided to investigate these mechanisms in erythrocytes to determine whether these brain defects represent generalized or genetic aberrations, in which case they should also be present in blood cells. The glutathione cycle has been investigated (reduced and oxidized glutathione, glutathione reductase and peroxidase) plus the activities of catalase and superoxide dismutase. The basal malonaldehyde content of erythrocytes was used as an index of endogenous lipid peroxidation. None of the above-mentioned parameters were found altered in erythrocytes of parkinsonians, suggesting that no genetic or generalized biochemical abnormalities underly the deficiencies detected in substantia nigra.
Similar articles
-
Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease.Neurosci Lett. 1988 May 3;87(3):307-10. doi: 10.1016/0304-3940(88)90467-3. Neurosci Lett. 1988. PMID: 3380350
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S82-7. doi: 10.1002/ana.410320714. Ann Neurol. 1992. PMID: 1510385 Review.
-
Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.J Neurol Sci. 1988 Sep;86(2-3):321-31. doi: 10.1016/0022-510x(88)90108-6. J Neurol Sci. 1988. PMID: 3221244
-
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.J Neural Transm (Vienna). 1997;104(6-7):661-77. doi: 10.1007/BF01291884. J Neural Transm (Vienna). 1997. PMID: 9444566
-
What process causes nigral cell death in Parkinson's disease?Neurol Clin. 1992 May;10(2):387-403. Neurol Clin. 1992. PMID: 1584181 Review.
Cited by
-
Effect of vitamin E deficiency on rat brain monoamine metabolism.Neurochem Res. 1999 Oct;24(10):1307-11. doi: 10.1023/a:1020937409855. Neurochem Res. 1999. PMID: 10492527
-
The Role of Oxidative Stress in Parkinson's Disease.Antioxidants (Basel). 2020 Jul 8;9(7):597. doi: 10.3390/antiox9070597. Antioxidants (Basel). 2020. PMID: 32650609 Free PMC article. Review.
-
Glutathione peroxidase in early and advanced Parkinson's disease.J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):679-82. doi: 10.1136/jnnp.54.8.679. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940936 Free PMC article.
-
Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.Neurol Sci. 2017 Mar;38(3):425-431. doi: 10.1007/s10072-016-2782-8. Epub 2016 Nov 30. Neurol Sci. 2017. PMID: 27900485
-
Parkinson's disease.CMAJ. 1989 Mar 1;140(5):507-14. CMAJ. 1989. PMID: 2563667 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical